Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tulika Chatterjee

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Rheumatology (Oxford, England)|April 2, 2023
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD studySasha Saadia Ali, Naveen R, Parikshit Sen, et al.
Rheumatology International|June 23, 2023
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD studyBohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, et al.
International Journal of Rheumatic Diseases|November 16, 2023
Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD studyNimrat Kaur Sandhu, Naveen Ravichandraan, Arvind Nune, et al.
Rheumatology (Oxford, England)|February 3, 2023
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveysParikshit Sen, Naveen R, Nazanin Houshmand, et al.
Rheumatology (Oxford, England)|July 28, 2023
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD studyLaura Andreoli, Daniele Lini, Karen Schreiber, et al.
Rheumatology (Oxford, England)|October 25, 2022
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD studyMrinalini Dey, Naveen R, Elena Nikiphorou, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Rheumatology (Oxford, England)|April 2, 2023
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD studySasha Saadia Ali, Naveen R, Parikshit Sen, et al.
Rheumatology International|June 23, 2023
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD studyBohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, et al.
International Journal of Rheumatic Diseases|November 16, 2023
Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD studyNimrat Kaur Sandhu, Naveen Ravichandraan, Arvind Nune, et al.
Rheumatology (Oxford, England)|February 3, 2023
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveysParikshit Sen, Naveen R, Nazanin Houshmand, et al.
Rheumatology (Oxford, England)|July 28, 2023
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD studyLaura Andreoli, Daniele Lini, Karen Schreiber, et al.
Rheumatology (Oxford, England)|October 25, 2022
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD studyMrinalini Dey, Naveen R, Elena Nikiphorou, et al.
Pageof 7